ABCELLERA BIOLOGICS INC (ABCL)

CA00288U1066 - Common Stock

3.31  +0.18 (+5.75%)

After market: 3.3686 +0.06 (+1.77%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
32.96M38.02M485.40M375.20M233.20M
Operating Expenses
341.03M275.23M268.90M170.80M77.10M
Research and Development
169.81M175.66M107.90M62.10M29.40M
Selling, General, and Administrative Expenses
85.40M75.18M66.80M48.80M15.80M
Operating Income
-308.06M-237.21M216.50M204.40M156.00M
Interest Income/Expense
44.67M46.15M12.00M-2.80M-2.80M
Other Income/Expense
61.22M17.03M10.60M17.50M8.30M
Non Recurring Items
N/AN/AN/AN/A-3.70M
Income Before Taxes
-202.17M-174.03M239.10M219.10M157.80M
Income Tax
-26.37M-27.63M80.60M65.70M38.90M
Net Income
-175.80M-146.40M158.50M153.50M118.90M
EBITDA
-222.28M-212.81M244.40M218.90M160.80M
 
Per Share Data
EPS Diluted Total Ops
-0.60-0.510.500.480.44
Non GAAP EPS
-0.61-0.520.500.47N/A
 
Statistics
Profit Margin
-533.32%-385.00%32.65%40.91%50.99%
Operating Profit Margin
-934.58%-623.82%44.60%54.48%66.90%

All data in USD

Charts